APA

Walters D. M., Lindberg J. M., Adair S. J., Newhook T. E., Cowan C. R., Stokes J. B., Borgman C. A., Stelow E. B., Lowrey B. T., Chopivsky M. E., Gilmer T. M., Parsons J. T. & Bauer T. W. (20130924). Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. : Neoplasia (New York, N.Y.).

Chicago

Walters Dustin M, Lindberg James M, Adair Sara J, Newhook Timothy E, Cowan Catharine R, Stokes Jayme B, Borgman Cheryl A, Stelow Edward B, Lowrey Bryce T, Chopivsky Maria E, Gilmer Tona M, Parsons John T and Bauer Todd W. 20130924. Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. : Neoplasia (New York, N.Y.).

Harvard

Walters D. M., Lindberg J. M., Adair S. J., Newhook T. E., Cowan C. R., Stokes J. B., Borgman C. A., Stelow E. B., Lowrey B. T., Chopivsky M. E., Gilmer T. M., Parsons J. T. and Bauer T. W. (20130924). Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. : Neoplasia (New York, N.Y.).

MLA

Walters Dustin M, Lindberg James M, Adair Sara J, Newhook Timothy E, Cowan Catharine R, Stokes Jayme B, Borgman Cheryl A, Stelow Edward B, Lowrey Bryce T, Chopivsky Maria E, Gilmer Tona M, Parsons John T and Bauer Todd W. Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. : Neoplasia (New York, N.Y.). 20130924.